Healthcare Triangle Inc. Approves Issuance of Shares for Acquisition of Niyama Healthcare Assets and Ezovion Solutions

Reuters10-15
<a href="https://laohu8.com/S/HCTI">Healthcare Triangle</a> Inc. Approves Issuance of Shares for Acquisition of Niyama Healthcare Assets and Ezovion Solutions

Healthcare Triangle Inc. has announced that its board of directors and shareholders have taken action on key corporate matters. The decisions were finalized as of September 19, 2025, with formal documentation signed by Chief Financial Officer David Ayanoglou. The company's common stock continues to trade on the Nasdaq Capital Market under the symbol "HCTI." The full filing can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-098801), on October 14, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment